Oct. 20 Chef s Table at Mick and Mack s: Grecian Gods and Goddesses
Grecian Gods and Goddesses Chefs Table, presented by Chef John Brewster
Thursday, October 20, 2016 with first course served at 5:30 p.m.
Mick & Macks Contemporary Café
Tangeman University Center, Level 3
Starters:
- Lemon Chicken Soup Avgolemono
- Moussaka
Entrées:
- Pastitso with Cold Greek Salad
- Lamb Chop with Greek Bean Salad and Sautéed Spinach
Dessert:
- Greek Custard Pie with Syrup
- Tulumba Trifle
Featured Bourbon Pairings:
- Ferrara Greco di Tufo
- Cantina del Taburno Fidelis Aglianico
- Bortolotti Processo
To RSVP:
To make a reservation, please call 513-556-3135 or email
.
Three-course meal and three distinct wines: $20 per person. Other beverage selections available. Must be 21 or older and present valid ID to buy and consume alcohol.
Save the Dates:
- Thursday, October 27, Local Beer Tasting: 50 West, with the first beer served at 5:30 p.m.
- Thursday, November 3, Wine & Spirits Tasting: Great Gastro Pub Grub, with the first drink served at 5:30 p.m.
View the full 2016-2017
Think Thursdays!
schedule at
.
And think about reserving Mick & Macks for YOUR next event!
Mick & Mack's Café logo
Mick & Macks Contemporary Café
Tangeman University Center, Level 3
uc.edu/mick_macks
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
An expert pieced together this Roman document like a puzzle
September 1, 2026
National media highlighted a new project by UC Classics Assistant Professor Matthijs Wibier to piece together and translate an ancient Roman text from fragments buried in the desert for more than 1,600 years.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.